Chile 2026 National Tecnovigilancia System Guide Draft: Status and Duties

1. Key takeaways

On August 27, 2026 the ISP opened a public consultation on the National Tecnovigilancia System Guide (Guía sobre el Sistema Nacional de Tecnovigilancia), with the consultation period running until September 27, 2026. The document is intended to replace previous versions and sets out explicit reporting time limits and procedures for manufacturers, importers and distributors. For the first time at guide level, the draft addresses the three commercial actors directly rather than only healthcare institutions, and it attaches named forms, named roles and named deadlines to each duty.

As of the verification date of October 29, 2026, the document remains a public consultation draft and has not yet entered into force; the previous system (Norma General Técnica N° 204) continues to apply in the meantime. The draft itself is an administrative document without legal force, which makes the status question a matter of professional accuracy rather than a technicality. GRZAN’s recommendation is concrete: reserve response capacity against the draft time limits, but do not present them externally as current obligations. A company that builds its procedures around the draft now, and documents that the procedures are provisionally aligned with a proposed text, will be able to switch over within days of publication instead of redesigning under pressure.

2. Legal basis

• ISP public consultation | National Tecnovigilancia System Guide | launched August 27, 2026; consultation period until September 27, 2026 | Scope: manufacturers, importers and distributors of medical devices and IVDs, as well as public and private healthcare institutions, military and police-force institutions, and device users.
• The guide’s own statement | an administrative document without legal force | the ISP retains the power to request supplementary information and to set requirements not expressly stated in the guide.
• Current system | Norma General Técnica N° 204 | issued December 21, 2018, published in the Official Gazette January 16, 2019 | continues to apply until the tecnovigilancia guide formally enters into force.
• Regulation on the control of pharmaceutical products and medical devices | Decreto Supremo N° 825, de 1998 | August 21, 1999 | Article 28: post-market reporting obligations.

3. Expert insights

Insight one: the legal status must be stated clearly — this is the dividing line between professional and unprofessional work.

A consultation draft is not legally binding, and the guide itself describes the guide in its preamble as an administrative document. Treating the draft as though it were already effective law creates a cost mismatch: budgets, staffing and supplier commitments get locked against requirements that may still change in the final text. Ignoring the draft completely has the opposite defect — when the final guide is published, the company is caught unprepared against deadlines measured in working days. The disciplined position is to hold both facts at once: current obligations live in Norma N° 204 and DS 825/1998, while the draft is a credible forecast of what those obligations will become.

Insight two: duty holders expand from healthcare institutions first to manufacturers, importers and distributors on an equal footing.

The guide expressly applies to manufacturers, importers and distributors and sets independent duties for each of the three: formally appointing a tecnovigilancia responsible person and a backup, establishing local collection and analysis procedures, reporting using the designated forms within the stated time limits, managing FSCA and recalls, and keeping records. None of these duties can be discharged by pointing to another actor in the chain. For foreign manufacturers without a local office, this makes the choice of Chilean licence holder and the contractual allocation of vigilance work a central design decision, not an afterthought in a distribution agreement.

Insight three: reports go through the integrated vigilance system (Sistema Integrado de Vigilancia).

The guide requires reports to be submitted through the integrated vigilance system and designates the forms: ANDID/006 (devices) and ANDID/010 (IVDs) for adverse events, and ANDIM/012 for FSCA and recalls. The form numbers are execution-level information and must be written into internal SOPs. Procedures that say submit the report through the ISP system without naming the form and the channel produce hesitation precisely at the moment when hours matter, especially for the shortest deadline tier.

Insight four: the guide reserves the ISP’s power to impose additional requirements.

The guide describes itself as an administrative document and expressly states that the ISP retains the power to request supplementary information and to set requirements the guide does not state. This means the guide is a floor, not a ceiling, of obligations. A company cannot defend itself against a case-specific ISP request by arguing that the guide does not mention it. Systems should therefore be designed with headroom: record retention beyond the stated minimum, response capacity beyond the stated deadlines, and a designated person empowered to answer ad hoc queries.

4. Practical recommendations

1. Establish a tracking mechanism for the final guide: complete a gap comparison against the draft within 48 hours of ISP publication and update SOPs accordingly, recording what changed and what it affects.
2. Reserve response capacity against the draft time limits, but in all external communication describe them explicitly as proposed requirements, pending verification, so that commitments made to partners remain accurate.
3. Write the form numbers into internal SOPs: ANDID/006, ANDID/010, ANDIM/012, together with the submission channel and the person authorised to file.
4. Appoint the tecnovigilancia responsible person and the backup in advance, so that no interim appointment is needed on the day the final guide enters into force.
5. Design the system on the assumption that the guide is a floor, keeping response margin for additional ISP requirements rather than calibrating every procedure to the stated minimum.

5. Verification checklist

• □ Confirmed that the guide is a consultation draft and has not entered into force as of the verification date
• □ A 48-hour gap comparison mechanism after final publication is in place
• □ Internal SOPs include the ANDID/006, ANDID/010 and ANDIM/012 form numbers
• □ The tecnovigilancia responsible person and backup have been appointed in advance
• □ The system retains response margin for additional ISP requirements

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers, importers and authorised representatives with post-market compliance in Chile, including tecnovigilancia reporting, FSCA and recall execution, record-keeping systems and SEREMI inspection response. For a product-specific feasibility assessment or post-market compliance support for the Chilean market, contact the GRZAN regulatory team at info@grzanglobal.com.